Cargando…

Epstein−Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas

Cancer cells subvert host immune surveillance by altering immune checkpoint (IC) proteins. Some Epstein−Barr virus (EBV)-associated tumors have higher Programmed Cell Death Ligand, PD-L1 expression. However, it is not known how EBV alters ICs in the context of its preferred host, the B lymphocyte an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anastasiadou, Eleni, Stroopinsky, Dina, Alimperti, Stella, Jiao, Alan L, Pyzer, Athalia R, Cippitelli, Claudia, Pepe, Giuseppina, Severa, Martina, Rosenblatt, Jacalyn, Etna, Marilena P, Rieger, Simone, Kempkes, Bettina, Coccia, Eliana M, Sui, Shannan J Ho, Chen, Christopher S, Uccini, Stefania, Avigan, David, Faggioni, Alberto, Trivedi, Pankaj, Slack, Frank J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327052/ https://www.ncbi.nlm.nih.gov/pubmed/29946193 http://dx.doi.org/10.1038/s41375-018-0178-x

Ejemplares similares

Differential regulation of miR-21 and miR-146a by Epstein–Barr virus-encoded EBNA2
por: Rosato, P, et al.
Publicado: (2012)

MUC1‐C drives myeloid leukaemogenesis and resistance to treatment by a survivin‐mediated mechanism
por: Stroopinsky, Dina, et al.
Publicado: (2018)

Epstein-Barr virus: From kisses to cancer, an ingenious immune evader
por: Trivedi, Pankaj, et al.
Publicado: (2018)

The Epstein-Barr Virus EBNA1 Protein
por: Frappier, Lori
Publicado: (2012)

Dendritic Cell Therapies for Hematologic Malignancies
por: Weinstock, Matthew, et al.
Publicado: (2017)

EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells
por: Glaser, Laura V., et al.
Publicado: (2017)

Immunotherapy for the treatment of multiple myeloma
por: Boussi, Leora S., et al.
Publicado: (2022)

The Nefarious Nexus of Noncoding RNAs in Cancer
por: Anastasiadou, Eleni, et al.
Publicado: (2018)

Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators
por: Ricci, Daniela, et al.
Publicado: (2021)

EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus–infected B cells
por: Beer, Sophie, et al.
Publicado: (2022)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Dendritic Cell Cancer Vaccines: From the Bench to the Bedside
por: Katz, Tamar, et al.
Publicado: (2014)

Contributions of Epstein–Barr Nuclear Antigen 1 (EBNA1) to Cell Immortalization and Survival
por: Frappier, Lori
Publicado: (2012)

The Epstein-Barr virus EBNA1 protein modulates the alternative splicing of cellular genes
por: Boudreault, Simon, et al.
Publicado: (2019)

Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
por: Dheekollu, Jayaraju, et al.
Publicado: (2017)

Murine Cytotoxic T Lymphocytes Recognize an Epitope in an EBNA-1 Fragment, but Fail to Lyse EBNA-1–expressing Mouse Cells
por: Mukherjee, Siddhartha, et al.
Publicado: (1998)

Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity
por: Ponnusamy, Rajesh, et al.
Publicado: (2019)

Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application
por: Severa, Martina, et al.
Publicado: (2019)

Epigenetic Repression of p16(INK4A) by Latent Epstein-Barr Virus Requires the Interaction of EBNA3A and EBNA3C with CtBP
por: Skalska, Lenka, et al.
Publicado: (2010)

Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
por: Dheekollu, Jayaraju, et al.
Publicado: (2019)

EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers
por: Jiang, Lijun, et al.
Publicado: (2018)

Mycobacterium tuberculosis-induced miR-155 subverts autophagy by targeting ATG3 in human dendritic cells
por: Etna, Marilena P., et al.
Publicado: (2018)

Molecular Screening for Epstein-Barr virus (EBV): Detection of Genomic EBNA-1, EBNA-2, LMP-1, LMP-2 Among Vietnamese Patients with Nasopharyngeal Brush Samples
por: Lao, Thuan Duc, et al.
Publicado: (2017)

Impact of Mycobacterium tuberculosis RD1-locus on human primary dendritic cell immune functions
por: Etna, Marilena P., et al.
Publicado: (2015)

Differential Responses of Human Dendritic Cells to Live or Inactivated Staphylococcus aureus: Impact on Cytokine Production and T Helper Expansion
por: Cruciani, Melania, et al.
Publicado: (2019)

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)
Publicado: (1990)

PRIMA-1(MET )induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein
por: Stuber, György, et al.
Publicado: (2009)

STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency
por: Wang, Yuyan, et al.
Publicado: (2020)

Phase separation of Epstein-Barr virus EBNA2 protein reorganizes chromatin topology for epigenetic regulation
por: Yang, Yiting, et al.
Publicado: (2021)

Human plasmacytoid dendritic cells at the crossroad of type I interferon-regulated B cell differentiation and antiviral response to tick-borne encephalitis virus
por: Etna, Marilena P., et al.
Publicado: (2021)

Differential Gene Expression Patterns of EBV Infected EBNA-3A Positive and Negative Human B Lymphocytes
por: Hertle, Marie L., et al.
Publicado: (2009)

The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation
por: Friberg, Anders, et al.
Publicado: (2015)

Similarities between the Epstein-Barr Virus (EBV) Nuclear Protein EBNA1 and the Pioneer Transcription Factor FoxA: Is EBNA1 a “Bookmarking” Oncoprotein that Alters the Host Cell Epigenotype?
por: Niller, Hans Helmut, et al.
Publicado: (2012)

Human Cd4(+) T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
por: Münz, Christian, et al.
Publicado: (2000)

Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2
por: AlQarni, Sana, et al.
Publicado: (2018)

Characteristics of MGUS and Multiple Myeloma According to the Target of Monoclonal Immunoglobulins, Glucosylsphingosine, or Epstein-Barr Virus EBNA-1
por: Bosseboeuf, Adrien, et al.
Publicado: (2020)

Epstein–Barr virus EBNA2 phase separation regulates cancer‐associated alternative RNA splicing patterns
por: Peng, Qiu, et al.
Publicado: (2021)

EBNA3C Directs Recruitment of RBPJ (CBF1) to Chromatin during the Process of Gene Repression in EBV Infected B Cells
por: Kalchschmidt, Jens S., et al.
Publicado: (2016)

Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model
por: Ricci, Daniela, et al.
Publicado: (2023)

Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1)
por: Lu, Fang, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_c6n1nln6goa3efm8956o6541vc